The increase in the elderly population associated with a higher incidence of cancer strongly endorses palliative care (PC). Hypodermoclysis (HDC) is a feasible technique for drugs and fluids delivery at the home care setting.
Objectives:
To assess the use and benefits of HDC in patients with end-of-life cancer assisted by a single home-based palliative care program (HPCP) in Belo Horizonte, Brazil.
Methods:
This was a retrospective study that analyzed medical charts from patients with end-of-life cancer who were assisted by an HPCP in a 1-year period of time.
Results:
A total of 333 patients, 81.7% with advanced cancer, were included. The most frequent symptoms were fatigue (44.4%) and pain (43.2%). Hypodermoclysis was used in 77.5% of the patients for the administration of fluids or medicines. Continuous palliative sedation was applied to 70.5% of patients. The place of death was home for 90.2% of the patients.
Conclusion:
Receiving home care assistance with palliative intention may decrease the need for dying patients with cancer to visit emergency units, as their symptoms were well controlled. Hypodermoclysis was a safe and effective alternative for hydration and drug delivery when provided and supervised by an experienced team. The place of death is a reliable indicator of the quality of death, and, in this study, the HPCP allowed patients to die at home with their families. It is essential for PC professionals to understand the impact of HDC use at home care setting for patients with end-of-life cancer allowing the increase of quality of death indicators.
BrayFFerlayJSoerjomataramI, et al.Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
2.
FerrellBRTemelJSTeminS, et al.Integration of palliative care into standard oncology care: American Society of Clinical Oncology Clinical Practice Guideline update. J Clin Oncol. 2017;35(1):96–112.
3.
HuiDBrueraE. Models of integration of oncology and palliative care. Ann Palliat Med. 2015;4:89–98.
4.
SagaYEnokidoMIwataY, et al.Transitions in palliative care: conceptual diversification and the integration of palliative care into standard oncology care. Chin Clin Oncol. 2018;7(3):32.
5.
MaetensABeernaertKDeliensL, et al.Policy measures to support palliative care at home: a cross-country case comparison in three European countries. J Pain Symptom Manage. 2017;54(4):523–529.e5.
6.
SmithLS. Hypodermoclysis with older adults. Nursing. 2014;44(12):66.
7.
HumphreyP. Hypodermoclysis: an alternative to I.V. infusion therapy. Nursing. 2011;41(11):16–17.
8.
DalalSBrueraE. Dehydration in cancer patients: to treat or not to treat. J Support Oncol. 2004;2(6):467–479, 483. Review.
9.
FainsingerRL. Dehydration and rehydration. In: BrueraEHigginsonIRipamontiCvon GuntenC, eds. Textbook of Palliative Medicine. London, England: Hodder Arnold; 2006:727–735.
10.
SlesakGSchnurleJWKinzelE, et al.Comparison of subcutaneous and intravenous rehydration in geriatric patients: a randomized trial. J Am Geriatr Soc. 2003;51:155–160.
ArinzonZFeldmanJFidelmanZ, et al.HDC (subcutaneous infusion) effective mode of treatment of dehydration in long-term care patients. Arch Gerontol Geriatr. 2004;38(2):167–173.
13.
BrunoVG. HDC: a literature review to assist in clinical practice. Einstein (Sao Paulo). 2015;13(1):122–128.
14.
SassonMShvartzmanP. HDC: an alternative infusion technique. Am Fam Physician. 2001;64(9):1575–1578.
15.
ChernyNIESMO Guidelines Working Group. ESMO Clinical Practice guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation. Ann Oncol. 2014;25(suppl 3):iii143–152.
16.
DunphyKFinlayIRathboneG, et al.Rehydration in palliative and terminal care: if not—why not?Palliat Med. 1995;9(3):221–228. Review.
17.
FainsingerRLBrueraE. HDC (HDC) for symptom control vs. the Edmonton injector (EI). J Palliat Care. 1991;7(4):5–8.
18.
FinlayIGHigginsonIJGoodwinDM, et al.Palliative care in hospital, hospice, at home: results from a systematic review. Ann Oncol. 2002;13(suppl 4):257–264.
19.
HigginsonIJFinlayIGGoodwinDM, et al.Is there evidence that palliative care teams alter end-of-life experiences of patients and their caregivers?J Pain Symptom Manage. 2003;25(2):150–168.
20.
ArmentoVPGyselsMHigginsonIJ, et al.Home palliative care works: but how? A meta-ethnography of the experiences of patients and family caregivers. BMJ Support Palliat Care. 2017;7(4):0.
21.
AdsersenMThygesenLCJensenAB, et al.Is admittance to specialized palliative care among cancer patients related to sex, age, and cancer diagnosis? A nation-wide study from the Danish Palliative Care Database (DPD). BMC Palliat Care. 2017;16(1):21.
22.
SharmaRKPrigersonHGPenedoFJ, et al.Male-female patient differences in the association between end-of-life discussions and receipt of intensive care near death. Cancer. 2015;121(16):2814–2820.
HuiDMengYCBrueraS, et al.Referral criteria for outpatient palliative cancer care: a systematic review. Oncologist. 2016;21(7):895–901.
26.
HuiDBrueraE. Integrating palliative care into the trajectory of cancer care. Nat Rev Clin Oncol. 2016;13(3):159–171.
27.
GabrielJ. Subcutaneous fluid administration and the hydration of older people. Br J Nurs. 2014;23(14):S10, S12-4.
28.
VidalMHuiDWilliamsJBrueraE. A prospective study of hypodermoclysis performed by caregivers in the home setting. J Pain Symptom Manage. 2016;52(4):570–574.e9.
29.
KhanMYoungerG. Promoting safe administration of subcutaneous infusions. Nurs Stand. 2007;21(31):50–56.
30.
BrueraELegrisMAKuehnN, et al.HDC for the administration of fluids and narcotic analgesics in patients with advanced cancer. J Pain Symptom Manage. 1990;5(4):218–220.
31.
BrueraESalaRRicoMA, et al.Effects of parenteral hydration in terminally ill cancer patients: a preliminary study. J Clin Oncol. 2005;23:2366–2371.
32.
FrisoliJAde PaulaAPFeldmanD, et al.Subcutaneous hydration by HDC. A practical and low-cost treatment for elderly patients. Drugs Aging. 2000;16:313–319.
33.
JustinoETTuotoFSKalinkeLP, et al.Hipodermóclise em pacientes oncológicos sob cuidados paliativos [Hypodermoclysis for cancer patients under palliative care]. Cogitare Enfermagem. 2013;18(1):84–89.
34.
PontaltiGRodriguesESAFirminoF, et al.Via subcutânea: segunda opção em cuidados paliativos [Subcutaneous route: second option in palliative care]. Revista HCPA. 2012;32(2):199–207.
35.
KlepstadPRoslandJH. No pain, much gain. Acta Anaesthesiol Scand. 2011;55(4):375–376.
36.
JansenKSchaufelMARuthsS. Drug treatment at the end of life: an epidemiologic study in nursing homes. Scand J Prim Health Care. 2014;32(4):187–192.
37.
GiordanoCOnyinyechiNLSaraC. Hypodermoclysis: the modern use in care of an ancient therapeutic technic. J Hosp Palliat Med Care. 2018;1:003.
38.
AzevedoEFBarbosaMF. Manual De Cuidados Paliativos. Hipodermóclise: um método alternativo para infusão de fluidos e medicamentos pela via subcutânea. Rio de Janeiro, Brazil: Academia Nacional de Cuidados Paliativos—ANCP; 2009;186–189.
39.
AlexanderMCorriganAGorskiLHankinsJPeruccaR.Infusion nursing: an evidence-based approach. In: LouisSTIII, ed. American Association of Critical-Care Nurses. Columbia, SC: Elsevier Saunders Editore; 2010.
40.
GoarinCTCoguletV. Administration des médicaments par voiesous-cutanée em soins palliatifs [Drugs administration by subcutaneous route in palliative care]. Thérapie. 2010;65(6):525–532.
41.
GomesNSSilvaAMBDZagoLB, et al.Nursing knowledge and practices regarding subcutaneous fluid administration. Rev Bras Enferm. 2017;70(5):1096–1105.
ChernyNIRadbruchL. The board of the European association for palliative care. European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med. 2009;23:581–593.
WoodmanCBaillieJSivellS. The preferences and perspectives of family caregivers towards place of care for their relatives at the end-of-life. A systematic review and thematic synthesis of the qualitative evidence. BMJ Support Palliat Care. 2015;0:1–12.
50.
GomesBCalanzaniNCurialeV, et al.Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers. Cochr Database Syst Rev. 2013;6(7):1–279.
